Details for New Drug Application (NDA): 019897
✉ Email this page to a colleague
The generic ingredient in NORPLANT is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 019897
Tradename: | NORPLANT |
Applicant: | Population Council |
Ingredient: | levonorgestrel |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019897
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | IMPLANT;IMPLANTATION | Strength | 36MG/IMPLANT | ||||
Approval Date: | Dec 10, 1990 | TE: | RLD: | No |
Expired US Patents for NDA 019897
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Population Council | NORPLANT | levonorgestrel | IMPLANT;IMPLANTATION | 019897-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
Population Council | NORPLANT | levonorgestrel | IMPLANT;IMPLANTATION | 019897-001 | Dec 10, 1990 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription